213 related articles for article (PubMed ID: 34207092)
1. Ocular Involvement in Hereditary Transthyretin Amyloidosis: A Case Series Describing Novel Potential Biomarkers.
Minnella AM; Rissotto R; Maceroni M; Romano A; Fasciani R; Luigetti M; Sabatelli M; Rizzo S; Falsini B
Genes (Basel); 2021 Jun; 12(6):. PubMed ID: 34207092
[TBL] [Abstract][Full Text] [Related]
2. Deposits on Retinal Surface Seen on OCT in Ocular Amyloidosis.
Kakihara S; Hirano T; Matsuda Y; Takano D; Imai A; Miyahara T; Murata T
Ophthalmol Retina; 2021 Oct; 5(10):1005-1008. PubMed ID: 33422693
[TBL] [Abstract][Full Text] [Related]
3. Multimodal retinal imaging in a Chinese kindred with familial amyloid polyneuropathy secondary to transthyretin Ile107Met mutation.
Lv W; Chen J; Chen W; Hou P; Pang CP; Chen H
Eye (Lond); 2014 Apr; 28(4):452-8. PubMed ID: 24480837
[TBL] [Abstract][Full Text] [Related]
4. Ocular Manifestations in a Chinese Pedigree of Familial Amyloidotic Polyneuropathy Carrying the Transthyretin Mutation c.401A>G (p.Tyr134Cys).
Zhuang X; Sun Z; Gao F; Wang M; Tang W; Liu W; Wang K; Wu J; Jiang R; Xu G
Genes (Basel); 2022 May; 13(5):. PubMed ID: 35627273
[TBL] [Abstract][Full Text] [Related]
5. Ocular Manifestations of Familial Transthyretin Amyloidosis.
Reynolds MM; Veverka KK; Gertz MA; Dispenzieri A; Zeldenrust SR; Leung N; Pulido JS
Am J Ophthalmol; 2017 Nov; 183():156-162. PubMed ID: 28911993
[TBL] [Abstract][Full Text] [Related]
6. Transthyretin Ala36Pro mutation in a Chinese pedigree of familial transthyretin amyloidosis with elevated vitreous and serum vascular endothelial growth factor.
Zou X; Dong F; Zhang S; Tian R; Sui R
Exp Eye Res; 2013 May; 110():44-9. PubMed ID: 23438977
[TBL] [Abstract][Full Text] [Related]
7. Ophthalmological involvement in wild-type transthyretin amyloidosis: A multimodal imaging study.
Frizziero L; Salvalaggio A; Cosmo E; Cipriani A; Midena E; Briani C
J Peripher Nerv Syst; 2023 Dec; 28(4):586-596. PubMed ID: 37552555
[TBL] [Abstract][Full Text] [Related]
8. Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis - assessed with optical coherence tomography angiography.
Marques JH; Coelho J; Malheiro J; Pessoa B; Beirão JM
Amyloid; 2021 Mar; 28(1):66-71. PubMed ID: 32996337
[TBL] [Abstract][Full Text] [Related]
9. OCULAR MANIFESTATIONS OF ASP38ALA AND THR59LYS FAMILIAL TRANSTHYRETIN AMYLOIDOSIS.
Choi KJ; Son KY; Kang SW; Kim D; Choi JO; Kim HJ; Kim JS; Jeon ES; Kim AY; Kang MC; Kim SJ
Retina; 2022 Feb; 42(2):396-403. PubMed ID: 34483316
[TBL] [Abstract][Full Text] [Related]
10. Ocular Involvement in Hereditary Amyloidosis.
Minnella AM; Rissotto R; Antoniazzi E; Di Girolamo M; Luigetti M; Maceroni M; Bacherini D; Falsini B; Rizzo S; Obici L
Genes (Basel); 2021 Jun; 12(7):. PubMed ID: 34206500
[TBL] [Abstract][Full Text] [Related]
11. Vutrisiran: A Review in Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis.
Nie T; Heo YA; Shirley M
Drugs; 2023 Oct; 83(15):1425-1432. PubMed ID: 37728865
[TBL] [Abstract][Full Text] [Related]
12. THAOS - The Transthyretin Amyloidosis Outcomes Survey: initial report on clinical manifestations in patients with hereditary and wild-type transthyretin amyloidosis.
Coelho T; Maurer MS; Suhr OB
Curr Med Res Opin; 2013 Jan; 29(1):63-76. PubMed ID: 23193944
[TBL] [Abstract][Full Text] [Related]
13. Corneal confocal microscopy identifies corneal nerve loss and increased Langerhans cells in presymptomatic carriers and patients with hereditary transthyretin amyloidosis.
Thimm A; Carpinteiro A; Oubari S; Papathanasiou M; Kessler L; Rischpler C; Malik RA; Herrmann K; Reinhardt HC; Rassaf T; Kleinschnitz C; Hagenacker T; Stettner M
J Neurol; 2023 Jul; 270(7):3483-3491. PubMed ID: 37014422
[TBL] [Abstract][Full Text] [Related]
14. Ganglion cell loss in early glaucoma, as assessed by photopic negative response, pattern electroretinogram, and spectral-domain optical coherence tomography.
Cvenkel B; Sustar M; Perovšek D
Doc Ophthalmol; 2017 Aug; 135(1):17-28. PubMed ID: 28567618
[TBL] [Abstract][Full Text] [Related]
15. Familial Oculo-Leptomeningeal Transthyretin Amyloidosis Caused by Leu55Arg Mutation.
Kleefeld F; Knebel F; Eurich D; Schatka I; Blüthner E; Schönfeld S; Amthauer H; Hahn K
J Neuromuscul Dis; 2020; 7(4):515-519. PubMed ID: 32741838
[TBL] [Abstract][Full Text] [Related]
16. Ocular Morpho-Functional Evaluation in ATTRv Pre-Symptomatic Carriers: A Case Series.
Maceroni M; Falsini B; Luigetti M; Romano A; Guglielmino V; Fasciani R; Placidi G; D'Agostino E; Sasso P; Rizzo S; Minnella AM
Diagnostics (Basel); 2023 Jan; 13(3):. PubMed ID: 36766465
[TBL] [Abstract][Full Text] [Related]
17. Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases.
Beirão JM; Malheiro J; Lemos C; Beirão I; Costa P; Torres P
Amyloid; 2015; 22(2):117-22. PubMed ID: 26096568
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetic-Pharmacodynamic Modeling of Inotersen, an Antisense Oligonucleotide for Treatment of Patients with Hereditary Transthyretin Amyloidosis.
Yu RZ; Collins JW; Hall S; Ackermann EJ; Geary RS; Monia BP; Henry SP; Wang Y
Nucleic Acid Ther; 2020 Jun; 30(3):153-163. PubMed ID: 32286934
[TBL] [Abstract][Full Text] [Related]
19. A case of transthyretin-related cerebral amyloid angiopathy. The other side of hereditary transthyretin amyloidosis.
Lemarchant B; Lebouvier T; Delbeuck X; Gibier JB; Tard C
Acta Neurol Belg; 2022 Apr; 122(2):571-573. PubMed ID: 35040071
[TBL] [Abstract][Full Text] [Related]
20. Epigenetic profiling of Italian patients identified methylation sites associated with hereditary transthyretin amyloidosis.
De Lillo A; Pathak GA; De Angelis F; Di Girolamo M; Luigetti M; Sabatelli M; Perfetto F; Frusconi S; Manfellotto D; Fuciarelli M; Polimanti R
Clin Epigenetics; 2020 Nov; 12(1):176. PubMed ID: 33203445
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
